Investigational Oncolytic Immunotherapy May Help Treat Skin Cancers in Transplant Patients
RP1, an investigational oncolytic immunotherapy, may be an effective treatment option for solid organ transplant (SOT) recipients with advanced non- melanoma skin cancer, according to research presented at the American Association for Cancer Research (AACR) Annual Meeting 2024 in San Diego, CA. Oncolytic immunotherapy uses viruses to target and destroy cancer cells while also stimulating […]